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Abstract
Background: Sarcoptic mange, a parasitic disease caused by the mite Sarcoptes scabiei, is regularly reported on
wolves Canis lupus in Scandinavia. We describe the distribution and transmission of this parasite within the small
but recovering wolf population by analysing 269 necropsy reports and performing a serological survey on 198
serum samples collected from free-ranging wolves between 1998 and 2013.
Results: The serological survey among 145 individual captured Scandinavian wolves (53 recaptures) shows a
consistent presence of antibodies against sarcoptic mange. Seropositivity among all captured wolves was 10.1 %
(CI. 6.4 %–15.1 %). Sarcoptic mange-related mortality reported at necropsy was 5.6 % and due to secondary causes,
predominantly starvation. In the southern range of the population, seroprevalence was higher, consistent with
higher red fox densities. Female wolves had a lower probability of being seropositive than males, but for both
sexes the probability increased with pack size. Recaptured individuals changing from seropositive to seronegative
suggest recovery from sarcoptic mange. The lack of seropositive pups (8–10 months, N = 56) and the occurrence of
seropositive and seronegative individuals in the same pack indicates interspecific transmission of S. scabiei into this
wolf population.
Conclusions: We consider sarcoptic mange to have little effect on the recovery of the Scandinavian wolf
population. Heterogenic infection patterns on the pack level in combination with the importance of individual-
based factors (sex, pack size) and the north–south gradient for seroprevalence suggests low probability of
wolf-to-wolf transmission of S. scabiei in Scandinavia.
Keywords: Canis lupus, Grey wolf, Sarcoptes scabiei, Sarcoptic mange, Ectoparasites, ELISA, Red fox, Vulpes
vulpes, Wildlife disease
Background
Sarcoptic mange is an epizootic skin disease caused by
the mite Sarcoptes scabiei worldwide infesting over 100
mammalian hosts including wild and domestic canids
[1, 2]. The mite, burrowing through the stratum corneum,
causes the host to mount a humoral immunological re-
sponse [3–5]. Wolves Canis lupus infested by S. scabiei,
develop alopecia due to intense scratching and biting trig-
gered by a hypersensitive response and may become debili-
tated and emaciated due to secondary bacterial infections
and difficulties in catching the natural prey [1, 2, 6]. S. sca-
biei infections can reduce pack size, annual pack growth
rate and cause additive mortality [7, 8]. However, recovery
from even severe sarcoptic mange on wolves is reported
from northern Spain and Yellowstone National Park [7, 9].
S. scabiei actively seek olfactory and thermal stimuli
and are able to survive, in suitable environments, for up
to 19 days off the host. All life stages remain infective
for at least one-half to two-thirds of their survival time
[10]. Transmission normally occurs through close con-
tact between hosts and is assumed to be host-density
dependent [1] but also fomites in the host environment
can be a source of transmission [10]. In Yellowstone
National Park, the spatio-temporal patterns of S. scabiei
infestation on wolves are related to distance to the next
infested pack, indicating wolf-to-wolf transmission [7].
In Scandinavia interspecific transmission of S. scabiei
var. vulpes from red fox Vulpes vulpes is the most likely
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origin for mange in wolves, domestic dog Canis lupus
familiaris, arctic fox Alopex lagopus, lynx Lynx lynx and
domestic cat Felis catus [11, 12]. In northern Spain,
wolves are infested with S. scabiei originated from both
red foxes and ungulates, emphasising the prey-to-
predator transmission [13].
The wolf was regarded as functionally extinct in
Scandinavia during the late 1960’s. In 1983, two immi-
grant wolves from the Finnish-Russian wolf population
reproduced for the first time and became the founders
of the present Scandinavian wolf population, [14–16].
During the following 30 years, the population increased
from less than 10 individuals to an estimated size of ap-
proximately 400 wolves [17]. By 2013, only five Finnish-
Russian founders had genetically contributed to this
population, and severe inbreeding depression has been
confirmed [15]. Although mortality of Scandinavian
wolves is mainly human-caused [18], sarcoptic mange
may be an important cause of natural mortality [11].
Sarcoptic mange arrived in Scandinavia in the mid-
1970’s with devastating effects on the red fox population,
[19, 20]. A previous study focusing on immunoglobulin
E (IgE) levels found 14/57 Scandinavian wolves seroposi-
tive for sarcoptic mange [21]. Effects of sarcoptic mange
on the demography of the Scandinavian wolf population
remain unclear but have the potential to influence this
small, inbred population. Here we analyse and present
an overview of the distribution of sarcoptic mange in the
Scandinavian wolf population.
Between 1998 and 2013 a total of 198 serum samples
from live wolves were collected and analysed by two dif-
ferent enzyme-linked immunosorbent assays (ELISA)
and complemented by Western Blot. In addition, we
evaluated necropsy reports of 269 dead wolves collected
in Sweden between 2003 and 2013.
The aim of our study is to describe the occurrence of
sarcoptic mange in the Scandinavian wolf population
and to identify demographic and environmental factors
that relate to the probability of finding seropositive sam-
ples. Based on the literature and personal observations
we expected sarcoptic mange to be a minor threat to the
Scandinavian wolf population. We predicted the prob-
ability of sarcoptic mange occurrence to depend on
population level factors including red fox and wolf terri-
tory density rather than on individual-based factors such
as age and sex of wolves.
Results
Seropositivity on captured wolves
In total 178 of the 198 samples (89.9 %) (Tables 1 and 2)
were tested seronegative and 20 samples (10.1 %, Wilson
95 % CI 6.4 %–15.1 %) were tested seropositive. Mean
annual proportion of seropositive samples was 11.3 %
(SE 2.5 %), ranging from 40.0 % in 1999 (N = 5) to zero
in 2008 (N = 7) and 2010 (N = 15) (Fig. 1a). The annual
proportion of the wolf population that was sampled de-
creased during the study period (χ1,13 = 18.82; p < 0.01)
(Fig. 1b). The annual sample size did not allow for fur-
ther temporal analysis.
Among the 38 recaptured individuals, eight were
tested seropositive at least once. Six were seropositive at
first capture and four seronegative at recapture 1 year
later. Two individuals were seropositive both at first cap-
ture and at recapture 2 years later (Table 2).
In 61 of 95 territory sampling events, multiple wolves
were captured within the same territory. In 13 of these
61 sampling events, at least one individual was seroposi-
tive and there were always also seronegative wolves in
the same sampling event. In two family groups, both the
adult male and female tested seropositive but their cap-
tured pups (two each) were seronegative at time of cap-
ture. In eight territories, seropositive individuals were
recaptured and six tested seronegative at recapture. In
one territory, both the adult male and female were cap-
tured in two consecutive years, the male tested seroposi-
tive twice and the female seronegative twice.
Sarcoptic mange from wolves at necropsy
The average annual prevalence of sarcoptic mange
among dead wolves collected in Sweden between 2003
Table 1 Demographic distribution of the serum samples and
observed lesions indicating sarcoptic mange among the
captured individuals
Total number of
serum samples
Seropositive
serum samples
Pups Pups total 56 0
Females 28 0
Males 28 0
Single/Dispersing 0 0
Pair 0 0
Pack 56 0
Unclear pack structure 0 0
Alopecia reported 0 0
Adults Adults total 142 20
Females 66 6
Males 76 14
Single/Dispersing 11 1
Pair 54 6
Pack 71 13
Unclear pack structure 6 1
Alopecia reported 9 7
Pups are < 1 year old, adults > 1 year old. Single/Dispersing wolves are outside
the parental territory and have no territory established yet. Pairs are a male
and a female in an established territory. Packs are one or two reproducing
wolves with their < 2 year old offspring. Alopecia reported on the capture form
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Table 2 Results from ELISA and Western Blot analysis
ID Wolf Sampling date Sex Age class OD MSA – 1 OD Crude Result ELISAs Western Blots
9802 15.12.1998 Male Adult 0.71 0.83 ++ ++
9803 15.12.1998 Female Adult 0.73 0.91 ++ +
9808 27.01.2000 Male Adult 0.11 0.32 −+ –
0001 28.01.2000 Male Adult 1.54 2.18 ++ ++
0002 28.01.2000 Female Adult 0.11 0.09 – -
0003 28.01.2000 Female Juvenile 0.05 0.07 – -
0104 10.02.2001 Female Adult 1.14 1.20 ++ ++
0105 10.02.2001 Male Adult 1.66 1.96 ++ ++
0105 05.02.2003 Male Adult 0.76 0.73 ++ +
0109 12.02.2001 Male Adult 0.63 0.11 +− -
0109 08.12.2001 Male Adult 0.34 0.13 – -
0106 12.02.2001 Female Juvenile 0.11 0.14 – -
0111 21.12.2001 Female Adult 0.20 0.30 -? +
0203 13.01.2002 Female Adult 0.17 0.24 -? -
0208 26.01.2002 Male Adult 0.41 0.15 ?- -
0208 06.03.2003 Male Adult 1.32 1.30 ++ +
0215 01.02.2002 Male Adult 0.20 0.25 -? -
0214 05.03.2003 Male Adult 0.70 0.92 ++ +
0214 21.01.2004 Male Adult 0.41 0.65 ?+ +
0307 06.03.2003 Female Adult 0.15 0.23 -? -
0009 23.01.2004 Male Adult 0.36 0.13 ?- -
0504 14.03.2005 Male Adult 0.40 0.42 ?+ +
0506 16.03.2005 Male Adult 0.56 0.19 +− ?+
0506 09.03.2007 Male Adult 0.43 0.07 ?- -
0507 16.03.2005 Female Juvenile 0.26 0.15 – -
0507 08.02.2008 Female Adult 0.65 0.13 +− -
0601 27.01.2006 Female Adult 0.44 0.37 ?+ -
0606 01.02.2006 Male Adult 0.22 0.36 −+ +
0606 08.03.2007 Male Adult 0.12 0.20 –
0611 13.02.2006 Male Adult 0.22 0.25 -? +
0611 11.03.2007 Male Adult 0.43 0.21 ?? -
0704 07.03.2007 Female Adult 0.67 0.70 ++ +
0913 30.01.2009 Male Juvenile 0.10 0.35 −+ -
0916 11.02.2009 Male Adult 1.50 0.40 ++ +
0918 12.02.2009 Male Adult 1.01 0.80 ++ +
0918 11.02.2010 Male Adult 0.23 0.19 –
1004 10.02.2010 Female Juvenile 0.18 0.22 -? -
1114 21.03.2011 Female Adult 0.73 0.39 ++ +
1114 11.12.2011 Female Adult 0.98 0.37 ++ -
1114 06.02.2012 Female Adult 0.81 0.35 ++ ?-
1114 14.03.2013 Female Adult 1.19 0.37 ++ +
1202 16.12.2011 Male Adult 1.54 0.98 ++ +
OD MSA-1: Relative optical densities using the MSA-1 antigen in the ELISA, cut off are 0.35 (doubtful) and 0.499 (seropositive) respectively. OD Crude: Relative optical densities
using the crude antigen in the ELISA, cut off 0.2 (doubtful) and 0.299 (seropositive). Result ELISAs are corresponding to the OD values and decide between: + (positive),
− (negative) and ? (doubtful). Shown are all samples with either positive or doubtful results from one of the ELISA and five random selected with negative results
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and 2013 was 4.5 % (SE = 1.3 %, N = 269). In the same
period, seropositivity rate of sarcoptic mange among cap-
tured wolves in Sweden was 7.6 % (SE = 2.5 %, N = 112).
Of the total 21 wolves considered to have sarcoptic mange
at necropsy, ten were euthanized due to mange-caused
emaciated status (starvation and alopecia), two were il-
legally shot, two were shot during licence hunt, one was
culled to prevent predation on livestock, one was eutha-
nized after a traffic accident and five were found dead. Of
the five wolves found dead, four died due to mange-
related starvation and one after a traffic accident. In sum-
mary, 15 (5.6 %) of the known wolf mortalities reported
by the Swedish National Veterinary Institute (SVA) in
Sweden between 2003 and 2013 were either euthanized or
died because of sarcoptic mange. A systematic serological
survey was not carried out on the necropsied wolves, thus
it was not possible to include the necropsy data in to the
statistical analysis.
The age distribution of the 19 wolves with known age
and lesions of mange at necropsy was nine pups (5 to
12 months old; 47.3 %), seven juveniles (1 and 2 years
old 36.8 %), and three adults (2 to 6 years old 15.8 %).
The majority (9 and 7 respectively) of these wolves came
from two different wolf territories. In one territory the
adult pair and two 9 months old pups were captured. At
capture, the adults were seropositive, while the pups
were seronegative. However, the pups were euthanized
at the age of 15 and 19 months due to lesions from sar-
coptic mange [22]. One of them was seropositive at nec-
ropsy, while the serum of the other was not tested.
Probability of seropositive samples
All 56 pups captured within their parental territories,
were seronegative and did not show any lesions of sar-
coptic mange. They were therefore excluded from the
statistical analysis. Annual mean seroprevalence of the
adult population was 19.9 % (SE 6.5 %).
The model combining the population-level predictor
latitude and the individual-based interaction of sex and
pack size was the most parsimonious (Table 3). Accord-
ing to the relative AICc weight ratio, it had 1.5 higher
evidence than the next-best model, which included the
wolf territory density. Both models passed model valid-
ation with rs > 0.8 (Table 3), but rs is not penalized for
additional variables. By adding body condition or remov-
ing pack size, the models decreased in evidence but
remained within the AICc cut off value (Table 3). Lati-
tude correlated negatively with the likelihood of finding
seropositive adult wolves for all combinations of sex and
pack size except for females in pairs (Fig. 2a, Table 4).
The probability of finding seropositive adult wolves was
6.1 to 8.2 times higher in the southern part (eg UTM 6
600 000, seroprevalence males 36.5 %, females 10.5 %) in
packs with 6 wolves (mean size of reproducing packs),
as compared to the northern edge of the wolf distribu-
tion. The probability of finding seropositive adult males
increased linearly with pack size, from 6.6 % seropreva-
lence in pairs to 38.9 % seroprevalence in packs of eight
wolves in the southern part of the study area. For adult
females in the same area, the model predicted a sero-
prevalence of 37.1 % for packs of eight wolves. No adult
female from a pair without pups was seropositive, the
model predicts a seroprevalence < 1 %.
Red fox harvest data was available for 49 Swedish ter-
ritory centre points throughout the study period. There
was no difference in red fox densities between territories
with seropositive wolves (harvested red fox per 1000 ha
± SE = 1.6 ± 0.5) and territories with only seronegative
wolves (harvested red fox per 1000 ha ± SE = 1.4 ± 0.2)
(t = −0.31, df = 9.4; p = 0.77). However, the fox harvest
Fig. 1 The proportion of seropositive samples (a) and the sample
size as the percentage of the Scandinavian wolf population (b).
Triangles (a) show the proportion of seropositive samples to the
sampled number of wolves each year (grey line). Solid dots (b) show
the percentage of sampled wolves. The grey line (b) represents the
mean number of individual wolves reported in Scandinavia with
error bars representing minimum and maximum estimations [17]
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decreased along the geographical gradient from the south-
ern to the northern most territories (Fig. 3; r2 = − 0.59,
df = 43, p < 0.001).
Discussion
The higher probability to find Scandinavian wolves sero-
positive to sarcoptic mange in their southern population
range is consistent with a higher red fox density and
higher habitat productivity resulting in smaller wolf ter-
ritory size as described by J Mattisson, et al. [23] in these
southern latitudes. The positive association between
habitat productivity and frequency of mange on wolves
is also reported from Yellowstone National Park [7]. In
northern Spain reported seroprevalence (20 %, N = 17/88)
is two times higher than the seropositivity rate in Scandi-
navia. This difference may be related to higher wildlife
densities and more contact to livestock and domestic dogs
in Spain [9, 24]. However, we could not find a direct rela-
tionship between red fox density and the occurrence of
seropositive individual wolves. Reasons for this could be
that red fox bag statistics do not represent the density of
infectious red foxes especially after a regional mange out-
break [25], and the occurrence of infected wolves after a
mange peak in the red fox might be delayed [9]. Bag statis-
tics in general have been shown to be an appropriate
index to estimate population densities [25, 26].
Consistent with previous reports [7, 9], we found
wolves that had recovered from sarcoptic mange and
also cases of coexistence of seropositive wolves, both
with and without clinical symptoms, with seronegative
and healthy wolves within the territory. But we also had
other cases with high mortality on the pack scale. Co-
infection with other diseases in this population such as
canine distemper virus (CDV), causing immune depres-
sion, could lead to increased mortality [27, 28]. The risk
for a host to get infected may relate to the initial mite
load. Possibly a threshold needs to be reached to over-
whelm the host’s immune system, resulting in a high
total mite load and increased probability to spread the
disease. In humans, S. scabiei transmission usually oc-
curs in close body contact and patients carrying >100
adult female mites are much more likely to spread
Fig. 2 Probability of seropositive serum samples from captured wolves depending on sex, pack size and latitude. Dotted line for pairs, solid line
for a pack of six wolves and dashed for a pack with eight wolves. Both figures show the back transformed and averaged predictions of the
combined model with e(Combined/(1+Combined)
Table 3 Model selection for predictors of seroprevalence of sarcoptic mange in adult wolves captured in Scandinavia
Model Parameters K AICc ΔAICc ωi rs(SE)
Combined Lat + Sex * Pack Size 5 78.16 0 0.38 0.86(0.02)
+ Density Lat + Sex * Pack Size + Territory Density 6 79.00 0.84 0.24 0.86(0.03)
+ Body Condition Lat + Sex * Pack Size + Body Condition 6 79.04 0.88 0.24 0.59(0.03)
– Pack Size Lat + Sex 3 80.57 2.41 0.12 0.62(0.03)
Submodel intrinsic Sex * Pack Size 4 83.36 5.20 0.01 -
Submodel density Lat + Pack Size 3 84.83 6.67 0.01 -
Density Lat + Long + Pack Size + Territory Density 4 88.47 10.31 0 -
Intrinsic Sex * Pack Size + Body Condition + Age + Repro 6 90.41 12.25 0 -
Null model 1 1 92.00 13.84 0 -
Top models are validated by k-fold cross validation (rs). Lat / Long: Latitude and longitude of the territory centre point, Repro: Reproducing or non-reproducing
pair, Pack Size: Number of wolves within the territory, Territory Density: Mean Euclidian distance to the next three territory centre points, Body Condition: Individual
residual distance to the linear regression line of log body weight and log body length. Presented are the two main models (Intrinsic, Density), the top models for each
variable group, the model combining the top submodels, the combined model with variables ranking within the cut off in the variable group model selection and the
null model
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the disease than patients with lower mite rates [29].
Á Oleaga, et al. [9] reported mite rates of <100 iso-
lated mites on wolves and a negative relation of isolated
mites to the area of alopecic skin, suggesting a certain
ability to control the mite development. The hypersensi-
tive reaction leading to pruritus and alopecia might be
present even if the mite rate is low [6]. In Yellowstone Na-
tional Park, within-pack transmission occurs. Almberg et
al. [30] reported a 61 % increased risk of individual infec-
tion with a 10 % increased prevalence within packs and
that mortality hazards increased with the proportion of in-
fected pack members or ambient temperatures above
average but decreased with increasing prey availability.
The large proportion of young wolves among the
infested individuals at necropsy demonstrates their sen-
sitivity once infested with sarcoptic mange. In several
North American wolf populations, sarcoptic mange
decreased pup survival [8, 31, 32]. In Scandinavia, a large
part of the mange-infested subadult wolves at necropsy
came from only two territories and among the captured
individuals, none of the pups were seropositive. We can-
not rule out low detectability of infested pups due to
high mortality before sampling during winter. In this
case we would expect some seropositive survivors and, a
negative relation between seroprevalence in adults and
pack size. This is not supported by our findings. A sea-
sonal cycle on wolves with lesions of mange has been
observed in the Yellowstone National Park with peaks in
November on population scale and in January on pack
scale [30]. Our samples are collected between December
and March.
During winter, Scandinavian wolf pups may be sepa-
rated from their parents for a large part of the time even
though they do not leave the territory until dispersal and
do not generally contribute to the food acquirement of
the family group [33]. For these wolf pups, exposure to
live or recently-killed mange-infested red fox is likely to
be very low. Experimentally measured seroconversion in
domestic dogs and red foxes takes up to 1–5 weeks
post-infection and 1–3 weeks from onset of clinical signs
[3, 34] and persists for 1 to > 4.5 months after successful
treatment in domestic dogs [35]. Infected pups, 7 to
10 months old at capture, would likely be detected by
the ELISA. We suggest that wolf pups in Scandinavia are
less exposed to S. scabiei than adults.
In contrast to other studies on sarcoptic mange and
wolves [24, 30, 31], we found a lower probability of sero-
prevalence in adult females of small packs. Sex differ-
ences in the humoral response to sarcoptic mange are
found in Iberian ibex Capra pyrenaica hispanica infested
with S. scabiei and higher Immunoglobulin G (IgG)
levels in females than males [36]. Higher IgG levels in fe-
males could lead to a longer duration of measurable
antibody response potentially resulting, in contrast to
our findings, in a higher detectability. Considering the
observed recoveries, if higher antibody titres would lead
to a faster clearance of the mite, detectability could be
lower. IgG levels are currently not available for this data
set and IgE or IgA levels measured on a subset of the
wolf samples did not differ between males and females
nor between mange seropositive and seronegative sera
[21, 37] The observed positive correlation of mange
prevalence in adult female wolves with pack size may be
related to increased susceptibility to parasites during
parturition and lactation [6].
Due to the high sociality and the monogamous mating
system, sex differences in behaviour of breeding wolves
are expected to be small, except during the early stage of
nursing the pups [38]. Wolves display sexual dimorph-
ism as male wolves are 20–30 % heavier than females
[16, 39] and have a higher food intake [33, 40]. Exposure
Fig. 3 Harvested red fox per 1000 ha for each sampled Swedish
wolf territory along the latitudinal gradient (N = 49). Circles indicate
territories with only seronegative samples, and triangles indicate
territories with at least one seropositive sample in the
respective years
Table 4 Top model estimates explaining seroprevalence of
sarcoptic mange in adult wolves captured in Scandinavia
Factors Estimate SE Lower CI Upper CI
Intercept −57.16 26.3 5.56 108.76
Lat - 0.88 0.39 - 1.64 - 0.11
Sex female - 6.12 3.67 - 13.31 1.07
Pack Size 0.05 0.15 - 0.24 0.34
Sex female * Pack Size 0.76 0.46 - 0.15 1.66
Territory Density 0.02 0.02 - 0.01 0.05
Body Condition −4.09 3.53 - 11.01 2.82
Estimates are averaged among the four top models. Lat: Latitude of the
territory centre point, Pack Size: Number of wolves within the territory,
Territory Density: Mean Euclidian distance to the next three territory centre
points, Body Condition: Individual residual distance to the linear regression
line of log body weight and log body length
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might be higher for males if they spend more time on
carcasses shared with infested red foxes. The breeding
wolf pairs in Scandinavia move together and use their
territory equally during most of the year [23, 41]. How-
ever, we do not know if individual male and female
wolves have different predation patterns on red fox or
domestic dogs. Considering the assumption of restricted
mite development on wolves and the heterogenic pat-
terns on pack scale, individual variation regarding infec-
tion paths and immunological response might play an
important role. Our small sample size, not allowing us
to control for individual variation, might bias model
based estimates on individual factors such as sex. Indi-
viduals to be captured where chosen according to the re-
search- or management questions and sampling was
opportunistic. However, to our knowledge this is the lar-
gest serological survey for sarcoptic mange on free-
ranging wolves. This is a retrospective study, clinical
evaluation of the captured animals was not standardized,
did not classify mange lesions, or reports were incom-
plete. For seven of the 20 seropositive wolves, lesion
consistent with sarcoptic mange (alopecia) was noted at
capture. For five seropositive wolves normal fur was
noted at capture and for eight seropositive wolves infor-
mation was missing. Two wolves with seropositive test
results had clinical signs (alopecia) at capture. No skin
biopsies or skin scrapings have been conducted. We
therefore were not able to define a nominal reference
gold standard and do not report sensitivity and specifi-
city of the ELISA. We confirmed the diagnosis using two
ELISAs with different antigens in parallel and Western
Blot in addition. Previous studies reported sensitivity
and specificity of 92 and 96 % respectively, on domestic
dogs with acute sarcoptic mange and 95 and 98 % in
chronic cases applying the crude antigen [42]. For the
same ELISA, sensitivity and specificity of 95 and 83 %
respectively are reported on wild Norwegian red fox
[43]. We assume similar values for the wolves, consider-
ing the close phylogenetic relation of the domestic dog
and the red fox to the wolf. The ELISA using the MSA-1
along with the crude antigen is today used by SVA to
diagnose sarcoptic mange on domestic dogs but not vali-
dated yet. We consider the three analyses to comple-
ment each other and assume sensitivity and specificity at
least as high as in the validation studies.
Conclusions
Although continuously present, we do not consider sar-
coptic mange as a significant factor of the sustainability
and recovery of the Scandinavian wolf population. Wolf
pups are less exposed to the parasite and mange dynam-
ics in the wolf population are not related to the local
density of wolf territories. Heterogenic seroprevalence
distribution within the packs and repeated observed
recovery suggest an effective host - parasite response
and a restricted wolf-to-wolf transmission. This disease
cannot be regarded as a potential factor controlling
population growth at this stage of population develop-
ment. However, devastating mortality may occur on in-
dividual pack scale as a result of this parasite. The
higher probability of sarcoptic mange in the southern
part of the wolf distribution is probably related to land-
scape factors and red fox population dynamics. Sarcoptic
mange could potentially become more important along
with a southern expansion of the Scandinavian wolf
population. Future research should address the individ-
ual humoral response of wolves and other canids to S.
scabiei. In Scandinavia, the scale of research should in-
clude the entire carnivore guild for a more complete
view on the dynamics and effects of this important
disease.
Methods
Study area
The Scandinavian wolf population is located in central
Sweden and south-eastern Norway (between 59 and 62°N,
and 10–15°E) (Fig. 4) [17]. The area is primarily covered
by managed forest stands of Norway spruce Picea abies
and Scots pine Pinus sylvestris and wet lands, agricultural
areas and settlements covering minor areas, primarily in
the southern part of the wolf range [23]. The human
population density is less than 1/km2 in large areas of the
main wolf range [16]. The climate is continental with aver-
age temperatures of 15 °C in June and −7 °C in January
and the area is snow covered from December to March
with an average depth of 30–60 cm [41]. The main prey
species are moose Alces alces and roe deer Capreolus
capreolus, the latter mainly in the southern range of the
wolf area. Other prey species represent a minor propor-
tion of the diet [33, 44].
Serum collection and analysis
A total of 198 serum samples from 145 individual free-
ranging wolves of 54 different packs in Sweden and
Norway were analysed. All wolves were immobilized by
darting from a helicopter during winter (December-
March) between 1998 and 2013 as part of a long term
joint Scandinavian research project or by national man-
agement, both following standard capture procedures
[45] and in accordance with the NC3Rs ARRIVE guide-
lines for reporting animal research [46]. Captured ani-
mals were tagged with VHF or GPS collars and ear tags
or microchips and the identity further confirmed by
DNA- and pedigree analysis [15]. To change radio col-
lars or for translocations 38 individuals were recaptured
1–3 times (Table 5). A sampling event per territory was
defined as one or more wolves captured per winter
within a pack, including recaptures. Sampled animals
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were sexed (104 males, 94 females), weighed and mea-
sured. As a proxy for body condition, we used the re-
sidual distance from each individual to the linear
regression line of log body weight and log body length
(nose to base of the tail) estimated from all individuals
in the data set [47]. This residual index was no longer
correlated to body length (r = −0.01, df = 104, p = 0.94).
The animals were grouped into pups (<1 year old) and
adults. The age was estimated from tooth wear in adults
and pups were identified by the growth zone on the ra-
dius and ulna [48]. Based on movement data from GPS-
collared wolves, pups were assumed to be born in early
May [49]. The age of the sampled wolves ranged from 7
to 10 months for pups and over 10 years for adults. Age
was adjusted if pedigree analysis could prove the year of
birth. Clinical evaluation of the captured wolves was not
standardized but anomalies, such as previous injuries,
broken teeth or mange lesion, are mentioned on the
capture form. Blood was collected from the cephalic vein
using 8 ml sterile, evacuated serum-separator tubes with
gel and clot activator (Venosafe™, Terumo Europe N.V,
Leuven, Belgium). Serum was separated by centrifuga-
tion at 1500 rpm for 15 min the same day and kept
frozen until shipment to the laboratory (Department
of Virology, Immunobiology and Parasitology, SVA
Uppsala, Sweden).
Serum samples were analysed by running two parallel
ELISAs using a crude (S. scabiei var. vulpes extract) anti-
gen according to Bornstein et al. 1993 [34], modified by
a change of the substrate from 5-amino-2-hydroxyben-
zoic to 3-3-5 tetramethylebenzidin (TBM) and a recom-
binant major S. scabiei var. vulpes antigen (MSA-1)
respectively [50]. In each series, samples were tested in
duplicates and positive and negative control samples
from dogs were included. Optical density (OD) was
Table 5 Age and recaptures among the captured individuals
Recaptures
Captured
individuals
1 2 3 Total
samples
Pups 56 56
Pups, recaptured
as adults
13 5 1 19
Adults 89 25 6 3 123
Total 145 38 11 4 198
Pups are < 1 year old, adults > 1 year old
Fig. 4 Study area. Distribution of the Scandinavian wolf population (hatched), pack centre points of captured territorial wolves or pups displayed
as seropositive (N = 20) or negative (N = 178) according to the ELISA and the location of collected wolves with lesions of mange at necropsy
(N = 21). Due to data collection of several animals at the same location, symbols might be overlapping
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measured at 450 nm with a multiscan EX (Thermo
Labsystems, Vantaa, Finland). In order to get an OD
value relative to the positive control, mean OD values
for each duplicate were calculated and the mean OD of
a blank (PBS-T instead of a sample) subtracted. For valid
results, positive control OD values had to be between
0.8 and 1.6 for the crude antigen and between 0.7 and
2.0 for the MSA-1 antigen. OD values of the samples
were divided by the OD value of the positive control.
Positive results should reach > 0.3 for the crude antigen
and > 0.5 for the MSA-1, relative to the positive control.
Doubtful results were defined as 0.2–0.299 by the crude
antigen and 0.35–0.499 by the MSA-1 antigen, OD
values below 0.2 and 0.35 respectively were considered
to be negative.
Western Blot as previously described [3], was used to
confirm all seropositive samples, all doubtful samples
and all samples with different results between the two
ELISAs. In brief, the sarcoptes proteins in the crude
antigen extract were separated by their atomic weight
(kDa) on a nitrocellulose membrane. The samples were
exposed to the proteins. When positive, the antibodies
in the samples bound with the protein at 164 kDa or
147 kDa and 105 kDa. Samples with doubtful or positive
ELISA values but confirmed positive by Western Blot
were considered as seropositive.
The proportion of seropositive samples are presented
with confidence intervals estimated by the Wilson score
method [51].
Necropsy reports
After 2002, all dead wolves found in Sweden have been
delivered for standard necropsy at SVA. Serology as de-
scribed above (N = 15), microscopy (N = 4) or both (N = 2)
were part of the standard necropsy if clinical signs of sar-
coptic mange were detected. We compared observed sero-
positivity from captured Swedish wolves from 2003 to
2013 with the necropsy data.
Population data
The annual monitoring of the Scandinavian wolf popula-
tion for the entire study area was based on snow track-
ing, DNA-analyses of scats and radio/GPS collar data
[52]. This monitoring provided, for each winter, the total
number and geographical distribution of established
pairs and packs and estimates of pack- and population
size. We expressed wolf density at two spatial scales.
Within wolf territories, pack size represented the num-
ber of wolves per territory and ranged from one to ten
wolves. The samples were classified as from single
wolves, from pairs (two scent marking animals of oppos-
ite sex) or packs (one or two scent marking animals and
pups or yearlings). Wolves older than two years within
the parental territory and both parents present have
until the end of the study period not been detected by
the monitoring in Scandinavia [17]. At the landscape
level, we used distance to neighbouring packs as a proxy
for territory density. We estimated the territory densitiy
for each wolf territory and for each winter as the average
of the Euclidean distances between its centre point and
the centre points of the three nearest neighbouring wolf
territories using the spatstat package [53] in R 3.0.3 [54].
We estimated the centre point coordinates by averaging
VHF or GPS collar locations of territorial adult wolves,
and DNA collection sites for wolf territories without
radio-collared individuals.
We used latitude as a habitat productivity proxy and
checked for longitude effects. As a proxy of red fox
density for each wolf territory, we used the yearly num-
ber of red fox harvested per 10 km2. These bag statistics
were provided by the Swedish Association for Hunting
and Wildlife Management on the hunting management
unit level (mainly corresponding to a municipality) in
Sweden. Mange lesions or other qualitative measures of
the shot red fox were not reported. Using a two sample
t-test, we tested if occurrence of seropositive wolves was
related to high red fox densities. We used the red fox
harvest record from those hunting management units
that contained the centre points of the wolf territories.
Accordingly, we tested if the latitude of the centre points
was related to the red fox harvest record in the respect-
ive hunting management units.
Modelling seroprevalence
According to our hypothesis we formulated two full
models à priori: 1) The individual-based model corre-
lated the probability to find a seropositive serum sample
to individual-based intrinsic factors; reproductive state,
age, body condition, and the interaction of sex and pack
size, assuming more physical contact of reproducing fe-
males with their pups, as well as a potential negative ef-
fect on pup survival with seropositive females. 2) The
population-based model correlated the probability to
find a positive serum sample to territory density, and to
the projected, metric latitude and longitude of the wolf
territory. Territory size of Scandinavian wolves increases
with latitude, independently of available moose biomass
but related to landscape structure and climate [23]. We
did not include red fox density in this model because of
missing values for the Norwegian territories. The re-
sponse variable in both models was a binary term with 1
for seropositive and 0 for seronegative wolves, and
models were statistically estimated using logistic regres-
sion. Due to a low number of events (seropositive) the
risk of over-fitted models increases rapidly with every
included variable [55]. We formulated sub models with
fewer variables and included them in the selection.
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Within both variable groups sub-models performed bet-
ter than the full models (Table 3).
All analyses were done using statistical extensions
available in R 3.0.3 [54]. Despite the inclusion recaptured
individuals we did not include nested random factors to
the models. This decision was based on the lack of the
among-individual variance to the binary response vari-
able resulting in a negligible effect when included as a
random factor [56]. A large proportion of the individuals
(107 of 145, Table 5) were sampled only once. In
addition, the time interval between capture events was
long enough for individuals to change from seropositive
and seronegative and vice versa [34, 36]. The variance
inflation factor of any continuous variable was <1 indi-
cating no multicollinearity [57] and models did not show
outliers (Cook’s distance) [58].
We selected by parsimony for each full model the best
sub-model (lowest AICc using the R-package AICcmod-
vag, no cut off ). Then we used a cut-off point of delta
AICc = 4 to find the best combination of predictors from
both sub-models. Further, we used model-averaging to
present the effect sizes of the predictors of the models
within the cut-off [59]. Observations with lacking data
were omitted before model selection (N = 36). Robust-
ness of the selected models was verified by k-fold cross
validation. The models were run 100 times on a training
set including randomly selected 90 % of the data. Using
the estimates of the training set, probabilities of being
seropositive were predicted for the remaining 10 %. The
predicted values were sorted and grouped into 10 equal-
sized, ranked bins. For each bin, the frequency of sero-
positive individuals was correlated with the rank of the
bin using a Spearman rank correlation (rs). This process
was repeated 10 times and the mean values of rs are
presented.
For the modelling process we omitted 36 out of the
198 samples either because data on body condition were
missing (N = 21), the wolves were dispersing (N = 4) or
were immigrants from the Finnish-Russian population
resident but captured for translocation (N = 2). Four
samples from one individual were excluded due to
unclear results from both ELISA and Western Blot.
On average, 9.3 % (SE 1.4 %) of the estimated mean
Scandinavian wolf population was sampled each win-
ter (Fig. 1a).
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